Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Danielle M Lussier, John L Johnson, Pooja Hingorani, Joseph N Blattman
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 21; DOI: 10.1186/s40425-015-0067-z